| Prev Close | 17.97 |
| Open | 17.92 |
| Day Low/High | 17.83 / 18.49 |
| 52 Wk Low/High | 5.80 / 20.96 |
| Volume | 26.17M |
Trillium Therapeutics Inc. (TRIL)
18.44
0.47
2.62
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 105.00B |
| Market Cap | 1.94B |
| P/E Ratio | 5.92 |
| Div & Yield | N.A. (N.A) |
Latest News
Traders Hit the Buy Button: Here's What I'm Watching
Many of the stocks favored by speculative traders are coming on strong.
Trading the Russell Indices Rebalancing
In the weeks ahead, there's likely to be unusual increases in volume in a number of the stocks that are being added to the Russell 3000.
16 Biotechs I Like Even as a Lack of Liquidity Is Hurting the Market
Quite a few stocks are fading right now -- not due to poor fundamentals, but due to lack of buying interest.
2 Promising Small-Cap Biotech Stocks That Could Spurt Higher in Coming Months
Trillium Therapeutics and Provention Bio have products in the pipeline that could propel their shares upward.
Wrapping Up Some Classic Holiday Trading
Next week we are likely to see some shift in the focus of the market as we move back to macro and big picture issues.
There's a Resurgence in SPAC Names
The positive news is that small-caps continue to do well and there's some good trading in smaller names.
I'm Focusing on Quicker Trades: Here Are Two
We are seeing some reversals in the overreactions that occurred in the last two days.
Some Consolidation Is Taking Place
There's selling pressure but that's healthy and will help to give us some better entry points.
This Market Continues to Ignore Big Picture Worries
The primary focus is on trying to put more cash to work.
I'm Ringing the Register and Looking for the Next Potential Winners
This is a very healthy market and some consolidations and pullbacks would be advantageous for trading.
Here's Where I'm Seeing Solid Breakouts
As this healthy bounce boosts the market, I'm seeing opportunities in these special purpose acquisition companies.
My Shopping List Amid This Selloff
Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.
Here's My Biotechnology Shopping List
Biotechnology is always high risk but the right plays move unlike anything else.
There's Quite a Bit of Random Action in Small-Caps Today
The market trend is up and that's all that matters in the short term.
There Are 2 Types of Trading Markets: This Is the Good One
Here's what I'm trading and what's on my radar today.
The Market Can Remain Irrational Longer Than You Can Remain Solvent
If the market can't sell off on this news then what reason does it have to dip?
I'm Focused More on Stock Picks Than Indices
You need not be a rip-snorting bull to still find some stocks that look pretty good on a technical basis.
Here's How I'm Positioned and What I'm Holding
I see no reason to put much money into longer-term positions right now, but here are some of my biggest positions.
Overall Market Conditions Look Poor But There Are Hot Pockets of Trading Action
Stocks are not moving in highly correlated action, which favors stock-pickers and technical buyers.
There's No Reason to Believe That the Indices Are Going to Hold at This Point
It's looking like the trading range I've been talking about may be developing now.
Small-Cap Stocks Keep Traders Bullish: 2 Sectors to Watch
There is nothing in small-caps to suggest that they are as frothy as the big-caps.
Tuesday Was Telling About Today's Trading
One group that is starting to look interesting is Master Limited Partnerships.
Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed
Such unwarranted fears have depressed the sector, which could bounce back after Nov. 8.
Shark Bites: Market Responds With 'Deutsche Who?'
Report of settlement turns the market.
Both Bulls and Bears Are Looking for a Breakout
The end of the quarter is approaching and might impact action in individual names.
I Am One of the Underinvested Bulls Right Now
It's challenging to put cash to work but I'll keep digging.
These Biotech Names Are on My Radar
But I'm expecting that things will slow into the Fed news.
A Down Day, But No Cause for Alarm
Thin volume likely ahead of holiday weekend.